Journal of Intellectual Property Rights

Open Access Open Access  Restricted Access Subscription Access

Changing Dimensions of Drug Patents of Indian Pharmaceutical Industry


Affiliations
1 Department of Information Technology, Sector 9-D, Chandigarh – 160009, India
2 Department of Economics, GGDSD College, Sector 32, Chandigarh – 160030, India
3 Department of Economics, Punjab University, Sector 14, Chandigarh – 160014, India
 

The Patents Act, 1970 which provided for process patenting led to pharmaceutical revolution in the country as India witnessed a spectacular increase in generic manufacturers. The Patent Act, 2005 however is considered to be a major game changer as it provides for both process and product patents and will set the tone to shift away from reverse engineering to forward engineering. The growth in Patent activity reflects the development in science and technology of the nation. With the passing of Patent Act, 2005 and increase in Intellectual Property (IP) awareness amongst the Indian companies, they seem to be taking IP protection more seriously on a global level. The paper aims to bring about trend, growth and prospects of patenting in Indian Pharmaceutical Sector. Relative Specialisation Index (RSI) for pharmaceutical patents in India vis-àvis the whole world has been calculated to concur if its trend is uphill. An inter-country RSI analysis of top ten pharmaceutical markets in the world has been conducted to project India’s strength at the world level.

Keywords

Relative Specialization Index, World Trade Organization, Trade Related Intellectual Property Rights Agreement, Gross Domestic Product, General Agreement on Tariffs and Trade, Bolar Provision, Patent Office Journal, Economic Survey, Drug Patents, Pharmaceutical Sector, Patent Laws, Patent Trends, Pharmaceutical Markets.
User
Notifications
Font Size

  • Trubek D M, Towards a Social Theory of Law: An essay on the study of law and development, The Yale Law Journal, 82 (1) (1972), https://pdfs.semanticscholar.org/e083/afcc950da0b7260b86a457387aadeaba3556.pdf.

  • Davis K E & Trebilcock M, The relationship between law and development: Optimists versus skeptics, New York University Law and Economics Working Papers, (133) (2008), http://www.fgv.br/processoseletivo/md/Ingresso2017/The-Relationship-between-Law.pdf.

  • Aufmann D & Kraay A, Growth without governance, World Bank Policy Research Working Paper, (2928)(2002), http://siteresources.worldbank.org/INTWBIGOVANTCOR/Resources/growthgov.pdf.

  • Sherman B & Bentley L, The Making of Modern Intellectual Property Law: The British Experience: 1760-1911, Cambridge University Press, xx (220) (1999), http://assets.cambridge.org/97805215/63635/frontmatter/9780521563635_frontmatter.pdf.

  • Smith A, An Inquiry into the Nature and Causes of the Wealth of Nations, 1723-1790, London: printed for W. Strahan & T Cadell, 1776.

  • Schumpeter J A, The Theory of Economic Development: An Inquiry into Profits, Capital, Credit, Interest and the Business Cycle (Harvard Economic Studies, Harvard College, Cambridge, Massachusetts, USA), 1934.

  • Ulku H, R&D, Innovation, and Economic Growth: An Empirical Analysis, IMF Working Paper, 4 (185) (2004), https://www.imf.org/external/pubs/ft/wp/2004/wp04185.pdf.

  • World Patent Report: A Statistical Review, WIPO, (2008), http://www.wipo.int/ipstats/en/statistics/patents/wipo_pub_9 31.html.

  • Chaudhuri S, TRIPS Agreement and Amendment of Patents Act in India, Economic and Political Weekly, 37 (32) (2002), https://www.researchgate.net/publication/259874024_TRIPS_Agreement_and_Amendment_of_Patents_Act_in_India.

  • Balassa B, Trade Liberalisation and Revealed Comparative Advantage, The Manchester School, 33 (2) (1965) 99-123, https://onlinelibrary.wiley.com/doi/abs/10.1111/j.14679957.1965.tb00050.x.

  • Raju K D, WTO-TRIPS Obligations and Patent Amendments in India: A critical stocktaking, Journal of Intellectual Property Rights, 9 (2004) 226-241, http://nopr.niscair.res.in/bitstream/123456789/4874/1/JIPR%209%283%29%20226241.pdf.

  • Desai N Associates, Intellectual Property Law in India, 2015, http://www.nishithdesai.com/fileadmin/user_upload/pdfs/Research%20Papers/Intellectual_Property_Law_in_India.pdf.

  • Dhar B & Gopakumar K M, Effect of Product Patents on the Indian Pharmaceutical Industry, Centre for WTO Studies, IIFT Delhi, (2008), http://wtocentre.iift.ac.in/Papers/3.pdf.

  • Ghai D, Patent Protection and Indian Pharmaceutical Industry, International Journal of Pharmaceutical Sciences Review and Research, 3 (2) (2010) 43-48, http://www.globalresearchonline.net/journalcontents/Volume3issue2/Article%20008.pdf.

  • Chadha A, Destination India for Pharmaceutical Industry, Delhi Business Review, 7 (1) (2006) 1-8, https://www.isas.nus.edu.sg/wpcontent/uploads/media/isas_papers/ISAS_ Working_Paper_ 14.pdf.

  • Bergman A, FDI and Spillover Effects in the Indian Pharmaceutical Industry, School of Economics and Management, Lund University, (2006), http://lup.lub.lu.se/luur/download?func=downloadFile&recordOId=1338017 &fileOId=1646193.

  • Mitsumori Y, The Indian Pharmaceutical Industry, (Springer), 2018.

  • La Mattina, John, India’s Solution to Drug Costs: Ignore Patents and Control Prices – Except for Home Grown Drugs, Forbes, (April 2013), https://www.forbes.com/sites/johnlamattina/2013/04/08/indias-solution-to-drugcostsignore-patents-and-control-prices-except-for-homegrowndrugs/#39fab1462cba.

  • Tyagi S & Nauriyal D K, Profitability determinants in Indian drugs and pharmaceutical industry: An analysis of pre and post TRIPS period, Eurasian Journal of Business and Economics, 9 (17) (2016) 1-21, http://www.ejbe.org/EJBE 2016Vol09No17 p001TYAGI-NAURIYAL.pdf.

  • Boldrin M & Levine D K, Does intellectual monopoly help innovation, Review of Law and Economics, 5 (3) (2009) 991–1024, https://www.degruyter.com/view/j/rle.2009.5.3/rle.2009 .5.3.1438/rle.2009.5.3.1438.xml.

  • Kiran R & Mishra S, Research and development, exports and patenting in the Indian pharmaceutical sector: A post-TRIPS analysis, Eurasian Journal of Business and Economics, 5 (7) (2011) 53-67, http://ejbe.org/EJBE2011 Vol04No07 p53 KIRAN-MISHRA.pdf.

  • www.wipo.int (accessed on 7 January 2018).

  • Hu Albert G Z & Png I P L, Patent rights and economic growth: Evidence from cross-country panels of manufacturing industries, WIPO Publication, (2010), http://www.wipo.int/edocs/mdocs/mdocs/en/wipo_ip_econ_ge_5_10/wipo_ip_econ_ge_5_10_ref_huandpng.pdf.

  • Mahajan M M, Emergence of new R&D Paradigms in the Indian Pharmaceutical Industry: Post TRIPS Period, Journal Of Intellectual Property Rights, 16 (2011) 321-329, http://nopr.niscair.res.in/bitstream/123456789/12446/1/IJPR %2016%284%29%20321-329.pdf.

  • Ricardo D, On the Principles of Political Economy and Taxation (John Murray, London), 1817. Heckscher E F, The Effect of Foreign Trade on the Distribution of Income, Ekonomisk Tidskrift, (1919) 497-512; Ohlin B, Interregional and International Trade (Harvard University Press, Cambridge, Massachusetts), 1983.

  • Heckscher E F, The effect of foreign trade on the distribution of income, Ekonomisk Tidskrift, (1919) 497-512; Ohlin B, Interregional and International Trade (Harvard University Press, Cambridge, Massachusetts), 1983.

  • Vollrath T L, A theoretical evaluation of alternative trade intensity measures of revealed comparative advantage, Weltwirtschaftliches Archiv, 127 (2) (1991) 265-280, https://link.springer.com/article/10.1007/BF02707986.

  • Palan N, Measurement of Specialisation – The Choice of Indices, FIW Working Paper, (62) (2010), https://www.fiw.ac.at/fileadmin/Documents/Publikationen/W orking_Paper/N_062-Palan.pdf.

  • Amiti M, Specialisation Patterns in Europe, CEP Discussion Papers, (363) (1997), http://eprints.lse.ac.uk/20321/1/Specialis ation_Patterns_in_Europe.pdf.

  • Duranton G & Puga D, Diversity and specialisation in cities: Why, where and when does it matter? Urban Studies, 37 (3) (2000) 533-555, http://journals.sagepub.com/doi/10.1080/00 42098002104.

  • Frantzen D, Explaining production specialisation in OECD manufacturing: A study for the period 1970-1995, International Review of Economics, 53 (4) (2006) 603-626, https://link.springer.com/article/10.1007/BF03029766.

  • Bickenbach F B, Eckhardt & Krieger-Boden C, Closing the gap between Absolute and relative measures of localisation, concentration or specialisation, Papers in Regional Science, 92 (3) (2013) 465-479, https://onlinelibrary.wiley.com/doi /full/10.1111/j.1435-5957.2012.00460.x.

  • Aksnes Dag W, Leeuwen T N & Siversten G, The effect of booming countries on changes in the Relative Specialisation Index (RSI) on country level, Scientometrics, 101 (2) (2014) 1391-1401, https://dl.acm.org/citation.cfm?id=2678176.

  • Archibugi D & Pianta M, Measuring technological change through patents and innovation surveys, Technovation, 16 (9) (1996) 451-468, https://www.sciencedirect.com/science/article/pii/0166497296000314.

  • Malerba F & Montobbio F, Exploring factors affecting international technological specialisation: The role of knowledge flows and the structure of innovative activity, Journal of Evolutionary Economics, 13 (4) (2003) 411-434, https://link.springer.com/article/10.1007/s00191-003-0162-z.

  • Verspagen B, Measuring intersectoral technology spillovers: Estimates from the European and US Patent Office Database, Economic Systems Research, 9 (1) (1997) 47-65, https://www.tandfonline.com/doi/abs/10.1080/09535319700 000004.

  • Peter V & Bruno N, International science and technology specialisation: Where does Europe stand? European Commission, EU, (2010), https://ec.europa.eu/research /innovation-union/pdf/international_science_and_techno logy_ specialisation.pdf.

  • IP Australia, A patent analytics study on the Australian Pharmaceutical Industry, Department of Industry, Innovation & Science, Australian Government, (2015), https://www.ipaustralia.gov.au/tools-resources/publicationsreports/patent-analytics-study-australian-pharmaceutical-industry.

  • Bhatia Raj, International Trade Law: Interdisciplinary Theory and Practice, (Matthew Bender and Company), 4th Ed., 2008, https://cap-press.com/pdf/9780769869094.pdf.

  • Mehta P S, TRIPS and pharmaceuticals: Implications for India, Swiss Yearbook for Development Policy, (1998) 97106, https://journals.openedition.org/sjep/718.

  • Greene W, The Emergence of India’s Pharmaceutical Industry and Implications for the US Generic Drug Market, Office of Economics Working Paper, US International Trade Commission, 07 (2007), https://www.usitc.gov/publications/332/EC200705A.pdf.

  • Wan J, Drug Discovery and Development in India, BioPharm International, 28 (4) (2015), http://www.biopharm international.com/drug-discovery-and-development-india.

  • Industry Canada Research, Canada’s Pharmaceutical Industry and Prospects, (2013), https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01768.html.


Abstract Views: 321

PDF Views: 173




  • Changing Dimensions of Drug Patents of Indian Pharmaceutical Industry

Abstract Views: 321  |  PDF Views: 173

Authors

Manjul Vaidya
Department of Information Technology, Sector 9-D, Chandigarh – 160009, India
Sukrit Garg
Department of Economics, GGDSD College, Sector 32, Chandigarh – 160030, India
Charu Singh
Department of Economics, Punjab University, Sector 14, Chandigarh – 160014, India
Madhur Mohit Mahajan
Department of Economics, GGDSD College, Sector 32, Chandigarh – 160030, India

Abstract


The Patents Act, 1970 which provided for process patenting led to pharmaceutical revolution in the country as India witnessed a spectacular increase in generic manufacturers. The Patent Act, 2005 however is considered to be a major game changer as it provides for both process and product patents and will set the tone to shift away from reverse engineering to forward engineering. The growth in Patent activity reflects the development in science and technology of the nation. With the passing of Patent Act, 2005 and increase in Intellectual Property (IP) awareness amongst the Indian companies, they seem to be taking IP protection more seriously on a global level. The paper aims to bring about trend, growth and prospects of patenting in Indian Pharmaceutical Sector. Relative Specialisation Index (RSI) for pharmaceutical patents in India vis-àvis the whole world has been calculated to concur if its trend is uphill. An inter-country RSI analysis of top ten pharmaceutical markets in the world has been conducted to project India’s strength at the world level.

Keywords


Relative Specialization Index, World Trade Organization, Trade Related Intellectual Property Rights Agreement, Gross Domestic Product, General Agreement on Tariffs and Trade, Bolar Provision, Patent Office Journal, Economic Survey, Drug Patents, Pharmaceutical Sector, Patent Laws, Patent Trends, Pharmaceutical Markets.

References